Apotex Launches Suit Over Eisai's Aricept Patents
Canadian generics maker Apotex Inc. has fired off a declaratory judgment action asserting it is not infringing Eisai Co. Ltd.'s patents, in a move to secure federal approval for its generic...To view the full article, register now.
Already a subscriber? Click here to view full article